Does Quartz Health Solutions Cover Ambien?

At a glance
- Generic zolpidem / typically covered on Quartz preferred generic tier (Tier 1 or Tier 2)
- Brand-name Ambien / may require prior authorization or step therapy through generic first
- Typical generic copay range / $5 to $25 per 30-day supply depending on plan
- Quantity limits / most plans cap zolpidem at 10 tablets per 30 days
- FDA-approved indication / short-term treatment of insomnia characterized by difficulty with sleep initiation [1]
- Prior authorization / rarely needed for generic zolpidem, often required for brand or CR formulation
- Step therapy / Quartz may require trial of sleep hygiene or generic zolpidem before covering brand
- Appeal process / members can request a formulary exception if generic is not tolerated
- Telehealth option / Quartz virtual care visits can initiate zolpidem prescriptions
How Quartz Health Solutions Handles Zolpidem Coverage
Most Quartz Health Solutions plans include generic zolpidem on their formulary as a preferred generic medication. This means the drug sits on the lowest or second-lowest cost-sharing tier. The FDA approved zolpidem in 1992 for short-term insomnia treatment, and its generic status since 2007 has made it one of the most affordable prescription sleep aids available through commercial insurance.
Formulary Tier Placement
Quartz structures its drug formulary into multiple tiers. Generic zolpidem immediate-release tablets typically fall on Tier 1 (preferred generic), while the extended-release formulation (zolpidem ER, equivalent to Ambien CR) may sit on Tier 2 or Tier 3 depending on the specific plan year. Brand-name Ambien, if listed at all, usually occupies a non-preferred brand tier with substantially higher cost-sharing. The American Academy of Sleep Medicine (AASM) clinical practice guidelines recommend that clinicians discuss both benefits and risks before prescribing any sedative-hypnotic, a recommendation insurers use to justify utilization management steps.
Plan Variation Matters
Quartz offers several plan types: HMO, POS, Medicare Advantage, and marketplace plans under the Affordable Care Act. Each carries a distinct formulary. A Quartz HMO commercial plan may cover generic zolpidem with a $10 copay, while a Quartz Medicare Advantage plan might place it under Part D with different cost-sharing rules. The Centers for Medicare & Medicaid Services (CMS) requires all Part D plans to cover at least two drugs per therapeutic class, and sedative-hypnotics including zolpidem generally meet this threshold.
Understanding Prior Authorization and Quantity Limits
Quartz Health Solutions applies utilization management tools to zolpidem prescriptions, primarily quantity limits and occasionally prior authorization for non-generic formulations. These controls reflect both cost containment and clinical safety guidance from the FDA's boxed warning on complex sleep behaviors added in 2019.
Quantity Limits on Zolpidem
Most Quartz plans cap zolpidem at 10 tablets per 30-day fill. This aligns with prescribing recommendations that zolpidem should be used at the lowest effective dose for the shortest clinically necessary duration. A 2019 analysis published in JAMA Internal Medicine found that sedative-hypnotic prescriptions exceeding 30 days were associated with increased fall risk in older adults (OR 1.38, 95% CI 1.24 to 1.54). The quantity cap reflects this evidence.
When Prior Authorization Applies
Generic zolpidem immediate-release rarely triggers prior authorization on Quartz commercial plans. Prior authorization is more common for:
- Brand-name Ambien when a generic equivalent exists
- Zolpidem extended-release (Ambien CR equivalent) if the immediate-release form has not been tried
- Doses exceeding 10 mg for men or 5 mg for women per night
The gender-specific dosing distinction follows the FDA's 2013 dose reduction recommendation for women, based on pharmacokinetic data showing women clear zolpidem more slowly, leading to higher morning blood levels and impaired driving risk.
How to Request a Formulary Exception
If your prescriber determines that you need brand-name Ambien or a formulation not covered on your Quartz tier, a formulary exception request can be filed. This requires a letter of medical necessity from your provider documenting that the preferred alternative was tried and failed, caused adverse effects, or is contraindicated. Quartz must respond to standard exception requests within 72 hours for commercial plans and 72 hours (or 24 hours for expedited) for Medicare Advantage plans, per CMS Part D coverage determination rules.
What Zolpidem Costs on a Quartz Plan
Out-of-pocket costs for zolpidem vary by plan design, pharmacy choice, and whether you have met your deductible. Generic zolpidem is one of the least expensive prescription sleep medications available.
Typical Cost Ranges
On most Quartz commercial plans, generic zolpidem 5 mg or 10 mg tablets cost between $5 and $25 for a 30-day supply at an in-network pharmacy. If your plan has a deductible that applies to prescriptions, you may pay the full cash price (often $10 to $30 for generic) until the deductible is met. The average wholesale price of generic zolpidem has remained stable, and a 2023 report from the CDC's National Center for Health Statistics noted that zolpidem was among the 50 most commonly dispensed generic medications in the United States, with approximately 22 million prescriptions filled annually.
Preferred Pharmacy Networks
Quartz maintains preferred pharmacy networks where cost-sharing is lower. Using a Quartz preferred pharmacy (often large retail chains) instead of a non-preferred pharmacy can reduce your copay by $5 to $15 per fill. Mail-order pharmacy options through Quartz may offer 90-day supplies at a reduced per-unit cost, which is particularly relevant for patients whose prescribers authorize ongoing zolpidem use under close monitoring.
Comparing Brand vs. Generic Costs
Brand-name Ambien, if your prescriber writes a dispense-as-written prescription, may cost $200 to $400 per month without preferred tier placement. The FDA's Orange Book confirms that multiple manufacturers produce AB-rated generic zolpidem tablets, meaning these generics have demonstrated bioequivalence to brand Ambien through rigorous testing. For nearly all patients, the generic provides identical clinical benefit at a fraction of the cost.
Clinical Context: When Zolpidem Is Appropriate
Understanding when zolpidem is clinically indicated helps you have a productive conversation with your Quartz plan and prescriber about coverage.
First-Line Treatment Is Not a Pill
The American College of Physicians (ACP) recommends cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment for chronic insomnia in adults [2]. A 2015 meta-analysis in Annals of Internal Medicine (N=1,162 across 20 RCTs) found CBT-I improved sleep onset latency by a mean of 19.03 minutes (95% CI 14.12 to 23.93) and improved sleep efficiency, with effects that persisted after treatment ended, unlike pharmacotherapy [2].
Quartz may require documentation that CBT-I was considered, attempted, or deemed impractical before covering zolpidem beyond an initial short-term prescription. This is consistent with insurer step-therapy protocols based on ACP guidance.
FDA-Approved Dosing
Zolpidem immediate-release is approved for short-term use at these doses according to the FDA prescribing information:
- Women: 5 mg immediately before bedtime
- Men: 5 mg or 10 mg immediately before bedtime
- Elderly or hepatically impaired: 5 mg
The lower recommended starting dose for women was based on pharmacokinetic studies showing that 8 hours after a 10 mg dose, 15% of women had blood zolpidem levels above 50 ng/mL (the threshold associated with driving impairment), compared to 3% of men.
Duration of Use Considerations
Zolpidem's FDA labeling specifies short-term use, generally interpreted as 2 to 6 weeks. Prescriptions extending beyond this window may trigger Quartz's drug utilization review (DUR) system. A 2018 study in the Journal of Clinical Sleep Medicine found that 68% of zolpidem prescriptions in commercial insurance databases were refilled beyond 6 months, raising concerns about long-term dependence that insurers now address through quantity and refill limits [3].
Alternatives Covered by Quartz Health Solutions
If zolpidem is not the right fit or your Quartz plan requires step therapy, several alternatives are typically covered.
Other Sedative-Hypnotics on Quartz Formularies
Quartz formularies commonly include these sleep medications:
| Medication | Typical Tier | Common Copay Range | Notes | |---|---|---|---| | Zolpidem IR (generic Ambien) | Tier 1 | $5 to $15 | Most accessible option | | Eszopiclone (generic Lunesta) | Tier 1 to 2 | $10 to $25 | Approved for longer-term use | | Suvorexant (Belsomra) | Tier 3 | $40 to $75 | Dual orexin receptor antagonist | | Lemborexant (Dayvigo) | Tier 3 | $40 to $75 | Newer DORA agent | | Doxepin 3 mg to 6 mg (Silenor) | Tier 2 to 3 | $15 to $40 | Low-dose tricyclic for sleep maintenance | | Trazodone (off-label) | Tier 1 | $5 to $10 | Widely used off-label for insomnia |
A 2022 systematic review in The Lancet evaluated 154 RCTs (N=44,089) of pharmacological insomnia treatments and found that eszopiclone, lemborexant, and zolpidem all showed statistically significant improvements in sleep onset latency versus placebo at 4 weeks, though effect sizes were modest (standardized mean difference range: -0.30 to -0.63) [4].
Dual Orexin Receptor Antagonists
Suvorexant and lemborexant represent a newer drug class that blocks wakefulness-promoting orexin signaling rather than broadly depressing the central nervous system. The Endocrine Society has noted the relevance of the orexin system to metabolic regulation, and these drugs may carry lower abuse potential than benzodiazepine receptor agonists like zolpidem. A phase 3 trial of lemborexant (SUNRISE-2, N=949) published in JAMA Network Open demonstrated sustained efficacy over 12 months with a safety profile favorable for longer-term use [5].
Non-Pharmacological Coverage
Some Quartz plans cover CBT-I delivered through behavioral health providers or digital therapeutics platforms. The FDA cleared the first prescription digital therapeutic for insomnia (Somryst/Pear-004) in 2020, and select commercial plans have begun covering similar programs. Ask your Quartz plan representative whether digital CBT-I is a covered benefit under your behavioral health or pharmacy benefit.
How to Verify Your Specific Quartz Coverage
Every Quartz member should verify coverage details specific to their plan before filling a zolpidem prescription.
Steps to Confirm Coverage
- Log into your Quartz member portal and search the formulary tool for "zolpidem"
- Note the tier, quantity limit, and any prior authorization flags
- Call the Quartz pharmacy benefit number on the back of your member ID card
- Ask your prescriber to submit an electronic prior authorization (ePA) if required
- Compare pricing at your preferred pharmacy using the Quartz cost estimator tool
What to Do if Coverage Is Denied
If Quartz denies coverage for zolpidem or a specific formulation, you have the right to appeal. The Department of Health and Human Services mandates that all ACA-compliant plans provide an internal and external appeal process. For Quartz commercial plans, the internal appeal must be decided within 30 days for non-urgent requests. Medicare Advantage members have additional protections under the CMS appeals framework, including the right to an independent review entity (IRE) determination.
Manufacturer Savings Programs
If cost remains a barrier even with Quartz coverage, the generic price of zolpidem is typically low enough that manufacturer coupons are unnecessary. For brand-name Ambien CR, manufacturer copay assistance programs historically existed but have been discontinued following generic entry. GoodRx and similar discount platforms may offer pricing below your Quartz copay in some cases, though using a discount card means the purchase does not count toward your plan deductible or out-of-pocket maximum.
Safety Considerations Your Insurer Wants You to Know
Quartz's utilization management for zolpidem is grounded in documented safety concerns that every patient should understand.
FDA Boxed Warning
In April 2019, the FDA required a boxed warning on all sedative-hypnotics including zolpidem after identifying 66 cases of serious injuries or deaths associated with complex sleep behaviors (sleepwalking, sleep-driving, engaging in activities while not fully awake). Zolpidem is contraindicated in patients with a history of complex sleep behaviors.
Risks in Older Adults
The American Geriatrics Society Beers Criteria lists zolpidem as a potentially inappropriate medication for adults aged 65 and older due to increased sensitivity to sedative-hypnotics, elevated fall risk, and cognitive impairment concerns [6]. Quartz Medicare Advantage plans may apply stricter quantity limits or require additional clinical documentation for members over 65. A 2020 cohort study in BMJ (N=507,786) found that new sedative-hypnotic use in adults over 65 was associated with a 40% increased fracture risk in the first 30 days (adjusted HR 1.40, 95% CI 1.28 to 1.53) [7].
Drug Interactions
Zolpidem interacts with CNS depressants, including opioids, benzodiazepines, and alcohol. The FDA's opioid-sedative interaction warning applies, and Quartz's DUR system flags concurrent prescriptions of zolpidem with opioids or benzodiazepines. Your pharmacist may contact your prescriber before dispensing if such a combination is detected.
Zolpidem is metabolized primarily by CYP3A4, so concurrent use of strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) increases zolpidem exposure. The National Institutes of Health Drug Interaction Checker and product labeling recommend dose reduction when these combinations cannot be avoided.
Frequently asked questions
›Does Quartz Health Solutions cover Ambien?
›What tier is zolpidem on the Quartz formulary?
›Does Quartz require prior authorization for Ambien?
›Is there a quantity limit on zolpidem with Quartz?
›How much does generic Ambien cost with Quartz insurance?
›Can I get Ambien CR covered by Quartz?
›What sleep medications does Quartz cover besides Ambien?
›Does Quartz Medicare Advantage cover zolpidem?
›What do I do if Quartz denies my Ambien prescription?
›Is brand-name Ambien worth the extra cost over generic zolpidem?
›Does Quartz cover cognitive behavioral therapy for insomnia?
›Can I use a telehealth visit to get a zolpidem prescription through Quartz?
References
- U.S. Food and Drug Administration. Zolpidem tartrate labeling and approval history. https://www.accessdata.fda.gov/drugsatfda_cgi/index.cfm
- Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. https://annals.org/aim/fullarticle/2523703
- Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014;37(2):343-349. https://pubmed.ncbi.nlm.nih.gov/24497662
- De Crescenzo F, D'Alò GL, Ostinelli EG, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022;400(10347):170-184. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00878-9/fulltext
- Rosenberg R, Murphy P, Zammit G, et al. Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial. JAMA Netw Open. 2019;2(12):e1918254. https://pubmed.ncbi.nlm.nih.gov/31581294
- 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. https://pubmed.ncbi.nlm.nih.gov/36370331
- Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0174730. https://pubmed.ncbi.nlm.nih.gov/28448584
- U.S. Food and Drug Administration. FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. 2019. https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia
- U.S. Food and Drug Administration. FDA drug safety communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR. 2013. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-approves-new-label-changes-and-dosing-zolpidem-products-and
- U.S. Food and Drug Administration. FDA drug safety communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines. 2016. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or
- U.S. Food and Drug Administration. FDA authorizes marketing of first prescription digital therapeutic for treatment of insomnia. 2020. https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-prescription-digital-therapeutic-treatment-insomnia
- Centers for Medicare & Medicaid Services. Medicare prescription drug appeals and grievances. https://www.cms.gov/Medicare/Appeals-and-Grievances/MedPrescriptDrugApplGriev
- Centers for Disease Control and Prevention. National Center for Health Statistics. https://www.cdc.gov/nchs/index.htm
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- American Academy of Sleep Medicine. Clinical practice guidelines. https://aasm.org/clinical-resources/practice-standards/
- U.S. Department of Health and Human Services. https://www.hhs.gov/